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Introduction
The incidence and titers of serum anti-tissue and anti-
organ autoantibodies (autoAT) depend on the clinical
manifestations of autoimmune thyroid diseases and the
expressiveness of the autoaggression. Among a family of
anti-thyroid autoAbs the following ones should be
highlighted:
(1) canonical (anti-TG and anti-TPO) autoAbs as well
as combinatorial (bispecific: to TG and TPO simulta-
neously) autoAbs (so-called anti-TGPO autoAbs);
(2) autoAbs with the functional properties: anti-TSH-R
autoAbs (TSH-R autoAbs), and autoAbs with proteolytic
activity – Ab-proteases. Anti-thyroid autoAbs are occur-
ring in patients with thyroid dysfunction (hyper-or
hypothyroidism: 55-90% of cases) and in euthyroid indi-
viduals (3-8% of cases).
Canonical autoAT
Anti-thyroid autoAbs of different levels of specificity
which are dominated in a majority of patients with Graves’
disease (70% and more) are known to be presented by
canonical anti-TPO and anti-TG autoABs (60%) and, to a
lesser extent, by anti-TGPO autoAbs (less 40%) to be
canonical as well. Dynamics of anti-thyroid autoAbs
would depend on the severity of the autoaggression and
would result in the decrease prior to the early stages of the
remission or in the burst at a time point preceding the
exacerbation and/or the progression of the disease. There-
fore, pre-early (preclinical) diagnostic protocol could iden-
tify and define the risks of Graves’ disease to progress, and
to thus implement the in-time therapeutic intervention to
prevent the initiation of the pre-early (preclinical) stages of
the disease in the overall irreversible pathologic process.
Anti-TG autoAbs
Anti-TG autoAbs in Graves’ patients were established to
occur with a frequency of 50%.
Anti-TPO autoAbs
High-rate occurrence and serum titers of anti-TPO
autoAbs would illustrate common and featured compli-
cations and manifested forms of the disease (92-95% of
cases), as well as subclinical Graves’ disease (62-66%).
Anti-TGRO autoAbs
In patients with Graves’ disease highly-enriched popula-
tions of anti-TGPO autoAbs have been found.
A phenomenon of clustering of thyroid autoAbs
The most common triplet found in patients with mani-
fested forms of Graves’ disease is a serological panel of
anti-TG-anti-TPO-anti-TGPO autoAbs. To lesser extent,
the occurrence of a panel of the duplex anti-TPO-anti-
TGPO autoAbs. No anti-TG-anti-TGPO duplexes have
been identified in Graves’ disease.
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Functionally active autoAT
In patients with Graves’ disease featured by a high pre-
valence of functionally active autoAbs, in particular, the
TSH-R and Ab-proteases have been dominated.
TSH-R autoAbs
TSH-R autoAbs classified as functionally valuable Abs to
mimic functions of the hormone and to trigger the devel-
opment of the autoimmune disease by binding to the
receptor and subsequent stimulation of the thyrocytes to
be activated. One can distinguish TSH-stimulating Abs
(TCA) to raise the production of thyroid hormones and
TSH-blocking autoAbs (TBA), to block activation of the
receptor and to be involved in the development of
hypothyroidism and thyroid atrophy.
AT-proteases
The prevalence of AT-proteases in patients with Graves’
disease was reached to 77%. In this case, 60% of seroposi-
tive patients with AT-proteases belonged to a tandem
consisting of the TG-and TPO-Ab-specific proteases
simultaneously. In the early stages of Graves ‘disease
(with subclinical) TPO - specific antibody-protease in
general are the only ones: they are 50% of patients with
subclinical Graves’ disease and 30% - with goiter degree 0
(in which the AT-protease least active). The activity of
Ab-proteases increases during the destruction of the
thyroid (hypothyroidism): from stage to stage of sympto-
matic complicated course (activity increased in two or
more times). With a progression of the disease and the
development of hyperthyroidism is also identified a ten-
dency for the serological clustering to be raised.
Modern serodiagnostic protocols in practice of
endocrinologists
Today, there are no defined serological criteria to allow
for putting timely diagnosis of Graves’ disease. One way
of solving the problem is the use of functionally active
Abs (including Ab-protease). A special role in solving the
above-mentioned problems associated with the diagnosis
of syndromal forms of the hyperthyroidism (in particular,
in patients with thyroid functional autonomy) and/or
with the preclinical serodiagnostic protocols to identify
the preclinical stages of the illness and to thus predict the
latter would belong to a family of Ab-proteases as highly
specific molecular tools.
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